Log in to save to my catalogue

Use of tricyclic antidepressants and risk of glioma: a nationwide case–control study

Use of tricyclic antidepressants and risk of glioma: a nationwide case–control study

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4891498

Use of tricyclic antidepressants and risk of glioma: a nationwide case–control study

About this item

Full title

Use of tricyclic antidepressants and risk of glioma: a nationwide case–control study

Publisher

London: Nature Publishing Group UK

Journal title

British journal of cancer, 2016-05, Vol.114 (11), p.1265-1268

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Background:
A protective effect of tricyclic antidepressants (TCAs) against gliomas has been suggested by a small number of studies. We investigated this putative association in a nationwide setting.
Methods:
Using a case–control design, we identified all patients with histologically verified glioma (cases) in Denmark between 2000 and 2012...

Alternative Titles

Full title

Use of tricyclic antidepressants and risk of glioma: a nationwide case–control study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4891498

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4891498

Other Identifiers

ISSN

0007-0920

E-ISSN

1532-1827

DOI

10.1038/bjc.2016.109

How to access this item